The FDA classifies this recall as Class II, which the agency describes as a situation "in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote."

System integrates glucose biosensor with an AI-driven platform to show how food, activity, stress, sleep affect the body in real time

By Sneha S K and Bageshri Banerjee (Reuters) -The U.S. Food and Drug Administration on Thursday approved Ionis Pharmaceuticals' drug to prevent instances of severe swelling in various parts of the body of patients with a rare genetic disorder.

FDA recalls 7Up Zero Sugar Tropical Soda for being mislabeled full-sugar soda. The affected cans were sold in 12-packs in Alabama, Florida and Georgia. This was just classified as a Class II recall, meaning it may cause reversible health effects.

The FDA said it has begun publishing reports of adverse events concerning drugs on a daily basis, instead of quarterly, as it has in the past.

Shaman Botanicals has issued a formal response to the FDA’s recent warning letter on its 7-hydroxymitragynine (7-OH) products, backed by reports from leading researchers at Johns Hopkins, Harvard, UCLA,

The weight-loss drug Wegovy just got FDA approval to treat a common and serious liver condition known as MASH (Metabolic Dysfunction-Associated Steatohepatitis), adding to a long list of benefits associated with GLP-1 medications.

With skin cancer cases up 77% since 1994, the bipartisan legislation seeks to address regulatory hurdles that have blocked new sunscreen ingredients for decades.

The FDA cleared the first glucose monitoring system specifically designed for weight management from Signos, providing a new option for maintaining a healthy weight. The system uses a continuous glucose monitor,

Despite boasting a new owner, the Indiana manufacturing plant that Novo Nordisk picked up as part of its parent company's Catalent buyout last year continues to catch flak from the FDA. | Despite boasting a new owner,